Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma

Clinical trial NCT02150317 · UNKNOWN

Trial details

NCT number: NCT02150317
Sponsor: Eastern Hepatobiliary Surgery Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2014-01-01
Primary completion: 2016-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.